Jacek Olczak, Philip Morris International CEO, joins CNBC's 'Money Movers' to discuss the company's most recent earnings.
ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some ...
The U.S. Food and Drug Administration (FDA) recently approved the marketing of 20 Zyn nicotine pouches, marking the first time nicotine pouches ...
Zyn has taken the U.S. by storm. The nicotine pouch brand's boom came at an opportune time for parent company Philip Morris ...
Philip Morris International Inc.'s stock touched an record high on Thursday after it issued a profit outlook that topped Wall Street analyst expectations on strength in its smokeless-tobacco products.
Philip Morris International Inc. issued a profit outlook that topped Wall Street analyst expectations on strength in its smokeless-tobacco products, sending shares of the company higher in premarket ...
On January 17, the FDA authorized ZYNs for sale, claiming their benefit to tobacco users outweighed their risk to the public.
The Zyn case provides a good excuse for the administration to put the FDA on its radar. It’s beyond debate that smoking ...
But the nicotine limit doesn't apply to vaping products, nicotine pouches such as Zyn, hookahs ... under Trump's earlier administration by FDA Commissioner Scott Gottlieb. The FDA said the ...